Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
LJPC has been recommended by the nº1 ranked US biotech analyst, Steve Delco, working at Fortis. I have read his research and I am convinced there is great value at current prices below 6. I saw the arithmetics on the board, mines are a little bit different. Using a 20% discount rate and discounting CF 9 years from now, I think NPV of CF between now and 2010 is over 100 per share. To this add a residual PE multiple of 30x and you get to 700$ in 9 years , i.e. 116 bagger or a performance of 69% CAGR.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement